Download our sample pre-conference planner now or to get the full version, see other insights about bispecific therapies, or to learn more about Beacon please contacts us.
The 2022 ASCO conference is expected to highlight the latest clinical developments in the bispecific field. Our team of analysts have screened hundreds of abstracts in preparation for the presentations and posters release. So far, 90 abstract titles have been identified as relevant to trial or drug pages on Beacon Bispecific. We are also keeping track of any late-breaking abstracts (listed as ‘TBC’) and will be included in the post-conference report in June.
In this sample you will find abstracts have been categorized by clinical trial and preclinical drug data.
We hope you find this pre-conference planner sample useful and insightful!
Find out more
This insight and data is part of the subscription to Beacon Bispecific.
Speak with our Team
Our dedicated team is on hand to showcase how Beacon can help you find the answers to your bispecific questions.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements